Prescription Drug Marketing Investment- Chapter III agents to find the most viable investment model.docVIP

 PAGE \* MERGEFORMAT 8 Prescription Drug Marketing Investment: Chapter III agents to find the most viable investment model Adapted from the book, Cheng Zhao: lt;lt;Prescription Drug Marketing Investmentgt;gt; ISBN :978-7-5017-9933-6 / C #8226; 70 Of: Zhao Zheng Price: 32.00 yuan Folio: 16 open Version: China Economic Press Publication Date: August 2010 published Added suggestions: Marketing Section III to find the most viable investment model agency In recent years, pharmaceutical investment industry was dubbed the “stroke injury”, the reality proved as well. With the national health system reform and the introduction of a series of new policies, such as “two votes” system “must be manufacturer direct tender” , “a product of two rules,” “cracking down on commercial bribery” and other new regulations, the original investment model has been a huge impact, pharmaceutical investment seems to come to an end, many companies have lost confidence in investment. However, with years of experience in the pharmaceutical investment, I think the investment will not withdraw from the historical stage of pharmaceutical marketing, sales of pharmaceutical companies is still the main form of investment pattern will be practical in the future will be gradually improved and developed. Therefore, pharmaceutical companies, the current priority is based on the current medical environment, based on the actual situation, based on the company’s products and team, and should be professional, policy expertise, professional staff, professional services, process control, academic accuracy, well-organized (as shown in Figure 2-7, the agents find the most viable investment model can be achieved in the new period of investment across. To find the most viable investment model of professional agents, pharmaceutical enterprises are familiar with the target characteristics. Based on these characteristics of what you want, the agent can find the most viable investment model.